$360B Women's Health Ghost Market Report
The Ghost Market Report shines a spotlight on the massive, yet overlooked opportunities within women's health—a space we've termed the "Ghost Market." It explores critical healthcare gaps affecting millions of women, highlighting where current solutions are insufficient or entirely absent. Our analysis identifies key areas ripe for innovation and investment, aiming to direct funding and attention toward impactful novel solutions in women's health.

Top 10 Deals of 2026: ŌURA to Acquire Counsel Health for $625M
Every year, Amboy Street highlights the top 10 transactions in women’s health. The next deal in this year’s series is ŌURA’s agreement to acquire Counsel Health, an AI-native primary care company, for $625 million in cash.

Top 10 Deals of 2026: Ferring to Acquire Gameto for up to $1.38B
Every year, Amboy Street highlights the top 10 transactions in women’s health. The splashy news of the week, and the next blog in our series, is Ferring Pharmaceuticals’ agreement to acquire Gameto, a cell-engineering company reimagining IVF, in a deal worth up to $1.38 billion.

Top 10 Deals of 2026: Sun Pharma to Acquire Organon for $11.75B
Every year, Amboy Street highlights the top 10 transactions in women’s health. This year’s series starts with one of the largest women’s health mergers in history.

Top 10 Deals: Five Year Review
In 2021, we started our Top 10 Deals series to answer a question we kept hearing from VCs and LPs: does women's health actually produce exits? Five years and 50 deals later, the answer is clear. It does, and at a scale few predicted.

Top 10 Deals of 2025: Oura’s $11B Valuation and the Rise of Consumer Healthcare
Each year, Amboy Street publishes a Top 10 Deals of the Year series highlighting the most significant transactions in women’s health. For the last blog in the series, we spotlight a watershed deal in women’s health - Oura’s Series E valued at $11B.

Top 10 Deals of 2025: Laborie Acquires the JADA® System for $465M
Each year, Amboy Street publishes a Top 10 Deals of the Year series highlighting the most significant transactions in women’s health. This week, we spotlight a meaningful transaction in the maternal health space - Laborie’s acquisition of the JADA system.

Top 10 Deals of 2025: L Catterton and Amulet Capital Take Stake in US Fertility
Each year, Amboy Street publishes a Top 10 Deals of the Year series highlighting the most significant transactions in women’s health. This week, we spotlight a meaningful partnership in the fertility care space - L Catterton and Amulet Capital Partners taking stake in US Fertility.

Top 10 Deals of 2025: Remedy Meds to Acquire Thirty Madison for $500M
Each year, Amboy Street publishes a Top 10 Deals of the Year series highlighting the most significant transactions in women’s health. This week, we spotlight Remedy Meds’ $500M acquisition of Thirty Madison in women’s digital consumer health.

Top 10 Deals of 2025: KKR acquires Karo Healthcare for $3B
This week we highlight a notable transaction in consumer health: EQT sells Karo Healthcare to KKR for $3B.